Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer

CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer

US Patent 9075066 · Granted Jul 7, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic device supporting manufacture of semiconductor device and operating m2025
Method for preventing or treating cancer using SYT11 inhibitor2025
Method for preventing or treating cancer using SYT11 inhibitor2025
Display device and method of driving the same2025
Electrode binder composition for rechargeable battery and electrode mixture incl2025
Glycerol derivative, preparation method therefor, and immunomodulator comprising2025
Anode binder for lithium rechargeable battery, anode binder including cured comp2025
Method for enhancing extracellular vesicle production2025
Method and apparatus for controlling refresh period of extended memory pool2025
1,2-diacylglycerol compound, preparation method therefor, and immunomodulator co2025
Electrode binder composition for rechargeable battery and electrode mixture incl2024
Louver assembly capable of having mounted thereon solar cell panel2024